...
首页> 外文期刊>Clinical ophthalmology >Endothelial cell counts after Descemet’s stripping automated endothelial keratoplasty versus penetrating keratoplasty in Asian eyes
【24h】

Endothelial cell counts after Descemet’s stripping automated endothelial keratoplasty versus penetrating keratoplasty in Asian eyes

机译:Descemet剥离自动内皮角膜形状术后内皮细胞计数在亚洲眼中剥离自动内皮角膜形形术与渗透角膜术后

获取原文
           

摘要

Background: The purpose of this study was to compare endothelial cell counts after Descemet’s stripping automated endothelial keratoplasty (DSAEK) and penetrating keratoplasty in Asian eyes.Methods: This was a retrospective study of patients from our prospective Singapore Corneal Transplant Study cohort who received corneal transplantation in 2006–2008. We compared eyes that underwent DSAEK or penetrating keratoplasty for Fuchs’ endothelial dystrophy or pseudophakic and aphakic bullous keratopathy. Clinical data, and donor and recipient characteristics were recorded. Of 241 patients who met our inclusion criteria, 68 underwent DSAEK and 173 underwent penetrating keratoplasty. The main outcome measure was endothelial cell loss at 1 year. Secondary outcome measures were graft survival and visual outcomes at 1-year follow-up.Results: There were no significant differences in baseline characteristics of patients between the treatment groups. Percent endothelial cell loss at 1-year follow-up was greater in penetrating keratoplasty eyes (40.9% ± 2.9%) compared with DSAEK eyes (22.4% ± 2.3%; P < 0.001). DSAEK-treated eyes had significantly superior uncorrected visual acuity (mean difference = 0.42 ± 0.0059; P < 0.001) and best spectacle-corrected visual acuity (mean difference = 0.14 ± 0.032; P < 0.001) as compared with penetrating keratoplasty-treated eyes. Penetrating keratoplasty-treated eyes had worse astigmatism as compared with DSAEK-treated eyes (-3.0 ± 2.1 versus -1.7 ± 0.8; P < 0.001). Graft survival at 1 year was comparable in both groups, ie, 66/68 (97.0%) DSAEK-treated eyes versus 158/173 (92.0%) of penetrating keratoplasty-treated eyes had clear grafts (P = 0.479).Conclusion: We report lower percent endothelial cell loss comparing DSAEK and penetrating keratoplasty at 1-year follow-up in Asian eyes, with comparable graft survival rates in both groups.
机译:背景:本研究的目的是在DesCemet剥离自动内皮角色质术(Dsaek)和亚洲眼睛渗透角膜术后的内皮细胞计数。方法:这是从我们预期的新加坡角膜移植研究队列接受角膜移植的患者的回顾性研究2006 - 2008年。我们将眼睛与Fuchs的内皮营养不良或假角膜营养不良或假鼻囊肿和口鼻喉科病变进行了垂直或渗透角膜术的眼睛。记录了临床资料和供体和受体特征。符合我们纳入标准的241名患者,68例患Dsaek和173人进行了渗透的角膜术。主要结果措施是1年内皮细胞损失。次要结果措施是在1年的后续后期移植存活和视觉结果。结果:治疗组之间的患者的基线特征没有显着差异。与dsaek眼睛相比,1年后续随访的内皮细胞损失百分比更大(40.9%±2.9%)(22.4%±2.3%; p <0.001)。 Dsaek治疗的眼睛具有显着优越的未矫正视力(平均差异= 0.42±0.0059; p <0.001)和最佳的眼镜校正的视力(平均差异= 0.14±0.032; p <0.001),相比穿透的角膜形成术治疗的眼睛相比。与dsaek处理的眼睛相比1年的移植物存活在两组上可相当,即66/68(97.0%)Dsaek处理的眼睛与158/173(92.0%)的穿透性角膜形成术治疗的眼睛具有透明的移植物(p = 0.479)。结论:我们报告较低的内皮细胞损失百分比对亚洲眼中的1年随访的DSAEK和穿透角膜术,两组中的移植物存活率相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号